Saturday, October 07, 2017 4:08:47 PM
NO MENTION OF BIOTECH...NONE!
Moreover, the business plan is to acquire companies with 5-30M in revenue & 500K in cash, with the goal being to spin them off as publicly listed companies.
Clearly, by their current acquisition, they are targeting companies that need to be turned around. Buying companies that are bankrupt may actually be part of the business model.
IMO- Its the business model that will move us from pennies to weight, as was pumped in the letter. If Platt wanted in MJ, he already has a biotech company he could make a move with-No need for CWIR that.
There is so much solid verifiable DD here, why start the MJ hype? This is a solid & clean play. Let just let this climb on the merits of what is verifiable for the time being. Besides, why setup new investors to expect something that is only a very very remote possibility?
My posts are my personal opinion, DD, or thoughts that hopefully add value to the conversation.
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM